| Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry NJ Weinreb, J Charrow, HC Andersson, P Kaplan, EH Kolodny, P Mistry, ... The American journal of medicine 113 (2), 112-119, 2002 | 714 | 2002 |
| The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease J Charrow, HC Andersson, P Kaplan, EH Kolodny, P Mistry, G Pastores, ... Archives of internal medicine 160 (18), 2835-2843, 2000 | 674 | 2000 |
| Therapeutic goals in the treatment of Gaucher disease GM Pastores, NJ Weinreb, H Aerts, G Andria, TM Cox, M Giralt, ... Seminars in hematology 41, 4-14, 2004 | 560 | 2004 |
| Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response N Dekker, L van Dussen, CEM Hollak, H Overkleeft, S Scheij, ... Blood, The Journal of the American Society of Hematology 118 (16), e118-e127, 2011 | 302 | 2011 |
| Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage PK Mistry, J Liu, M Yang, T Nottoli, J McGrath, D Jain, K Zhang, J Keutzer, ... Proceedings of the National Academy of Sciences 107 (45), 19473-19478, 2010 | 279 | 2010 |
| The risk of Parkinson’s disease in type 1 Gaucher disease G Bultron, K Kacena, D Pearson, M Boxer, R Yang, S Sathe, G Pastores, ... Journal of inherited metabolic disease 33, 167-173, 2010 | 248 | 2010 |
| Consensus Conference: A reappraisal of Gaucher disease-diagnosis and disease management algorithms PK Mistry, MD Cappellini, E Lukina, H Özsan, SM Pascual, H Rosenbaum, ... American journal of hematology 86 (1), 110, 2011 | 236 | 2011 |
| Glucosylsphingosine promotes α-synuclein pathology in mutant GBA-associated Parkinson's disease YV Taguchi, J Liu, J Ruan, J Pacheco, X Zhang, J Abbasi, J Keutzer, ... Journal of Neuroscience 37 (40), 9617-9631, 2017 | 228 | 2017 |
| Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations J Charrow, HC Andersson, P Kaplan, EH Kolodny, P Mistry, G Pastores, ... The Journal of pediatrics 144 (1), 112-120, 2004 | 212 | 2004 |
| Pulmonary hypertension in type 1 Gaucher’s disease: genetic and epigenetic determinants of phenotype and response to therapy PK Mistry, S Sirrs, A Chan, MR Pritzker, TP Duffy, ME Grace, DP Meeker, ... Molecular genetics and metabolism 77 (1-2), 91-98, 2002 | 212 | 2002 |
| Clonal immunoglobulin against lysolipids in the origin of myeloma S Nair, AR Branagan, J Liu, CS Boddupalli, PK Mistry, MV Dhodapkar New England Journal of Medicine 374 (6), 555-561, 2016 | 204 | 2016 |
| Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists–oncologists and an opportunity for early diagnosis and intervention PK Mistry, S Sadan, R Yang, J Yee, M Yang American journal of hematology 82 (8), 697-701, 2007 | 203 | 2007 |
| The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients TH Taddei, KA Kacena, M Yang, R Yang, A Malhotra, M Boxer, KA Aleck, ... American journal of hematology 84 (4), 208-214, 2009 | 191 | 2009 |
| Individualization of long-term enzyme replacement therapy for Gaucher disease HC Andersson, J Charrow, P Kaplan, P Mistry, GM Pastores, ... Genetics in Medicine 7 (2), 105-110, 2005 | 187 | 2005 |
| Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients NJ Weinreb, MC Aggio, HC Andersson, G Andria, J Charrow, JTR Clarke, ... Seminars in hematology 41, 15-22, 2004 | 185 | 2004 |
| Glucosylsphingosine is a key biomarker of Gaucher disease V Murugesan, WL Chuang, J Liu, A Lischuk, K Kacena, H Lin, ... American journal of hematology 91 (11), 1082-1089, 2016 | 184 | 2016 |
| Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis GV Papatheodoridis, M Hamilton, PK Mistry, B Davidson, K Rolles, ... Gut 43 (5), 639-644, 1998 | 179 | 1998 |
| Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history HN Baris, IJ Cohen, PK Mistry Pediatric endocrinology reviews: PER 12 (0 1), 72, 2014 | 177 | 2014 |
| Outcome of orthotopic liver transplantation in patients with haemophilia FH Gordon, PK Mistry, CA Sabin, CA Lee Gut 42 (5), 744-749, 1998 | 176 | 1998 |
| Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1: the ENGAGE randomized clinical trial PK Mistry, E Lukina, HB Turkia, D Amato, H Baris, M Dasouki, M Ghosn, ... Jama 313 (7), 695-706, 2015 | 175 | 2015 |
